End-of-day quote
Other stock markets
|
||
- USD | 0.00% |
Mar. 26 | Transcript : SELLAS Life Sciences Group, Inc. - Special Call | |
Mar. 26 | SELLAS Life Sciences Group, Inc. Announces Positive Topline Data from the Phase 2a Study of Sls009 in r/r AML | CI |
- Stock
- Equities
- Stock SELLAS Life Sciences Group, Inc.
- Stock Galena Biopharma Inc - Nasdaq
- News Galena Biopharma Inc